Panagiotis Katsonis
Panagiotis Katsonis
Assistant Professor of Molecular and Human Genetics, Baylor College of Medicine
Dirección de correo verificada de bcm.edu - Página principal
Título
Citado por
Citado por
Año
Comprehensive and integrative genomic characterization of hepatocellular carcinoma
A Ally, M Balasundaram, R Carlsen, E Chuah, A Clarke, N Dhalla, RA Holt, ...
Cell 169 (7), 1327-1341. e23, 2017
7462017
Metastable liquid clusters in super-and undersaturated protein solutions
O Gliko, W Pan, P Katsonis, N Neumaier, O Galkin, S Weinkauf, ...
The Journal of Physical Chemistry B 111 (12), 3106-3114, 2007
1182007
Mitochondrial neurogastrointestinal encephalopathy due to mutations in RRM2B
A Shaibani, OA Shchelochkov, S Zhang, P Katsonis, O Lichtarge, ...
Archives of neurology 66 (8), 1028-1032, 2009
1092009
Evolutionary action score of TP53 identifies high-risk mutations associated with decreased survival and increased distant metastases in head and neck cancer
DM Neskey, AA Osman, TJ Ow, P Katsonis, T McDonald, SC Hicks, ...
Cancer research 75 (7), 1527-1536, 2015
922015
A formal perturbation equation between genotype and phenotype determines the Evolutionary Action of protein-coding variations on fitness
P Katsonis, O Lichtarge
Genome research 24 (12), 2050-2058, 2014
892014
Wee-1 kinase inhibition overcomes cisplatin resistance associated with high-risk TP53 mutations in head and neck cancer through mitotic arrest followed by senescence
AA Osman, MM Monroe, MVO Alves, AA Patel, P Katsonis, AL Fitzgerald, ...
Molecular cancer therapeutics 14 (2), 608-619, 2015
772015
Single nucleotide variations: biological impact and theoretical interpretation
P Katsonis, A Koire, SJ Wilson, TK Hsu, RC Lua, AD Wilkins, O Lichtarge
Protein Science 23 (12), 1650-1666, 2014
732014
Separation of recombination and SOS response in Escherichia coli RecA suggests LexA interaction sites
AK Adikesavan, P Katsonis, DC Marciano, R Lua, C Herman, O Lichtarge
PLoS Genet 7 (9), e1002244, 2011
592011
Deleterious effect of RAS and evolutionary high-risk TP53 double mutation in colorectal liver metastases
YS Chun, G Passot, S Yamashita, M Nusrat, P Katsonis, JM Loree, ...
Annals of surgery 269 (5), 917-923, 2019
572019
Evolutionary action score of TP53 coding variants is predictive of platinum response in head and neck cancer patients
AA Osman, DM Neskey, P Katsonis, AA Patel, AM Ward, TK Hsu, ...
Cancer research 75 (7), 1205-1215, 2015
572015
Molecular defects in human carbamoy phosphate synthetase I: mutational spectrum, diagnostic and protein structure considerations
J Häberle, OA Shchelochkov, J Wang, P Katsonis, L Hall, S Reiss, A Eeds, ...
Human mutation 32 (6), 579-589, 2011
482011
Desmosterolosis—phenotypic and molecular characterization of a third case and review of the literature
CP Schaaf, J Koster, P Katsonis, L Kratz, OA Shchelochkov, F Scaglia, ...
American journal of medical genetics Part A 155 (7), 1597-1604, 2011
362011
Specific TP53 mutants overrepresented in ovarian cancer impact CNV, TP53 activity, responses to nutlin-3a, and cell survival
LK Mullany, KK Wong, DC Marciano, P Katsonis, ER King-Crane, YA Ren, ...
Neoplasia 17 (10), 789-803, 2015
352015
Metastable mesoscopic phases in concentrated protein solutions
PG Vekilov, W Pan, O Gliko, P Katsonis, O Galkin
Aspects of Physical Biology, 65-95, 2009
342009
Molecular defects in human carbamoy phosphate synthetase I: mutational spectrum, diagnostic and protein structure considerations
J Haberle, OA Shchelochkov, J Wang, P Katsonis, L Hall, S Reiss, A Eeds, ...
Hum Mutat 32 (6), 579-589, 2011
272011
Corresponding-states laws for protein solutions
P Katsonis, S Brandon, PG Vekilov
The Journal of Physical Chemistry B 110 (35), 17638-17644, 2006
262006
Prediction and redesign of protein–protein interactions
RC Lua, DC Marciano, P Katsonis, AK Adikesavan, AD Wilkins, ...
Progress in biophysics and molecular biology 116 (2-3), 194-202, 2014
252014
Multiple extrema in the intermolecular potential and the phase diagram of protein solutions
S Brandon, P Katsonis, PG Vekilov
Physical Review E 73 (6), 061917, 2006
252006
Combinatorial inhibition of PTPN12-regulated receptors leads to a broadly effective therapeutic strategy in triple-negative breast cancer
A Nair, HC Chung, T Sun, S Tyagi, LE Dobrolecki, R Dominguez-Vidana, ...
Nature medicine 24 (4), 505, 2018
222018
Protein stabilization improves STAT3 function in autosomal dominant hyper-IgE syndrome
CE Bocchini, K Nahmod, P Katsonis, S Kim, MM Kasembeli, A Freeman, ...
Blood 128 (26), 3061-3072, 2016
202016
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20